Get started
Author

Faina Barer

The A3 Adenosine Receptor Is Highly Expressed in Tumor versus Normal Cells
2004 · Lea Madi, Avivit Ochaion, et al. · Clinical Cancer Research · 187
Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment
2009 · S. Bar‐Yehuda, L. Rath‐Wolfson, et al. · Arthritis & Rheumatism · 126
Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor
2000 · Gil Ohana, Sara Bar-Yehuda, et al. · Journal of Cellular Physiology · 123
PDF
The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease
2009 · A. Ochaion, S. Bar-Yehuda, et al. · Cellular Immunology · 119
The A3 Adenosine Receptor as a New Target for Cancer Therapy and Chemoprotection
2001 · Pnina Fishman, Sara Bar-Yehuda, et al. · Experimental Cell Research · 119
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells
2002 · Pnina Fishman, Lea Madi, et al. · Oncogene · 101
An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3β and NF-κB
2003 · Pnina Fishman, Sara Bar-Yehuda, et al. · Oncogene · 99
A3 Adenosine Receptor Activation in Melanoma Cells
2003 · Lea Madi, Sara Bar-Yehuda, et al. · Journal of Biological Chemistry · 99
Adenosine acts as an inhibitor of lymphoma cell growth
2000 · P. Fishman, S. Bar-Yehuda, et al. · European Journal of Cancer · 93
Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
2003 · Pnina Fishman, Sara Bar-Yehuda, et al. · PubMed · 89
Resistance of Muscle to Tumor Metastases: A Role for A3 Adenosine Receptor Agonists
2001 · Sara Bar-Yehuda, Faina Barer, et al. · Neoplasia · 86
PDF
CF102 an A3 adenosine receptor agonist mediates anti‐tumor and anti‐inflammatory effects in the liver
2010 · S. Cohen, S.M. Stemmer, et al. · Journal of Cellular Physiology · 78
Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level.
2007 · Lea Madi, Shira Cohen, et al. · PubMed · 75
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats
2008 · A. Ochaion, S. Bar-Yehuda, et al. · Biochemical Pharmacology · 70
Adenosine acts as a chemoprotective agent by stimulating G-CSF production: A role for A1 and A3 adenosine receptors
2000 · Pnina Fishman, Sara Bar-Yehuda, et al. · Journal of Cellular Physiology · 63
Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3adenosine receptor expression
2006 · Avivit Ochaion, Sara Bar-Yehuda, et al. · Arthritis Research & Therapy · 56
PDF
Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson
2018 · Shira Cohen, Faina Barer, et al. · Journal of Immunology Research · 41
PDF
The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice
2019 · Pnina Fishman, Shira Cohen, et al. · International Journal of Molecular Medicine · 40
PDF
A3Adenosine Receptor Allosteric Modulator Induces an Anti-Inflammatory Effect:In VivoStudies and Molecular Mechanism of Action
2014 · Shira Cohen, Faina Barer, et al. · Mediators of Inflammation · 27
Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice
1999 · Sara Bar-Yehuda, Tamar Farbstein, et al. · Clinical & Experimental Metastasis · 9
The anti-inflammatory and anto-fibrogenic effects of namodenoson in NAFLD/NASH animal models
2018 · P. Fishman, A. Salhab, et al. · Journal of Hepatology · 3
THU0064 The A3 Adenosine Receptor (A3AR): Therapeutic Target and Predictive Biological Marker in Rheumatoid Arthritis
2015 · S. Cohen, Z. Harpaz, et al. · Annals of the Rheumatic Diseases · 2
Effect of CF102 on growth suppression and apoptosis in an orthotopic model of hepatocellular carcinoma
2008 · S. Bar Yehuda, S. M. Stemmer, et al. · Journal of Clinical Oncology · 1
CF102 an A3 adenosine receptor agonist induces in vivo apoptosis of Hepatocellular carcinoma
2008 · S. Bar Yehuda, Salomon M. Stemmer, et al. · Cancer Research · 1
Over-expression of the A3 adenosine receptor in tumor and PBMC of hepatocellular carcinoma patients: A specific therapeutic target
2007 · P. Fishman, S. Stemmer, et al. · Journal of Clinical Oncology · 1
Works count: 34
Citation count: 1,709
H-index: 19
I10-index: 19
Year
Topic
Type